Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Paul Hudson
Brendan O'Callaghan
Brian Foard
Emmanuel Frenehard
Houman Ashrafian
Jean-Baptiste Chasseloup de Chatillon
Julie Van Ongevalle
Madeleine Roach
Natalie Bickford
Olivier Charmeil
Roy Papatheodorou
Thomas Triomphe
Board:
Frédéric Oudéa
Antoine Yver
Emile Voest
Wolfgang Laux
Anne-Francoise Nesmes
Barbara Lavernos
Carole Ferrand
Christophe Babule
Fabienne Lecorvaisier
Gilles Schnepp
Lise Kingo
Patrick Kron
Rachel Duan
Yann Tran
Shareholding in %:
Capital International Ltd. 0.81
Capital Research & Management Co. (Global Investors) 0.78
Capital Research & Management Co. (World Investors) 1.3
Dodge & Cox 1.78
Geode Capital Management LLC 0.77
L'Oréal SA 9.35
Norges Bank Investment Management 2.04
Sanofi 1.28
Schroder Investment Management Ltd. 0.69
The Vanguard Group, Inc. 3.23
Freefloat 77.97
Address: 46, avenue de la Grande Armée, 75017 Paris
T: +33-1-53-77-40-00
F: +33-1-53-77-44-03
I: http://www.sanofi.com
E: